Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

MiMedx Group, Inc

MDXG Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MDXG by members of U.S. Congress

MDXG Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MDXG Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDXG Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in MDXG holdings by institutional investors

Quarterly net insider trading by MDXG's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $30,000 Aug 03, 2026 Issue: Medicare/Medicaid
  • $20,000 Jul 20, 2026 Issue: Medicare/Medicaid
  • $30,000 May 18, 2026 Issue: Medicare/Medicaid
  • $20,000 Apr 20, 2026 Issue: Medicare/Medicaid
  • $30,000 Feb 05, 2026 Issue: Medicare/Medicaid
  • $20,000 Jan 14, 2026 Issue: Medicare/Medicaid
  • $30,000 Nov 06, 2025 Issue: Medicare/Medicaid
  • $20,000 Oct 17, 2025 Issue: Medicare/Medicaid
  • $30,000 Jul 25, 2025 Issue: Medicare/Medicaid
  • $20,000 Jul 09, 2025 Issue: Medicare/Medicaid
  • $30,000 May 06, 2025 Issue: Medicare/Medicaid
  • $20,000 Apr 16, 2025 Issue: Medicare/Medicaid
  • $30,000 Feb 05, 2025 Issue: Medicare/Medicaid
  • $20,000 Jan 10, 2025 Issue: Medicare/Medicaid
  • $30,000 Nov 08, 2024 Issue: Medicare/Medicaid
  • $20,000 Oct 18, 2024 Issue: Medicare/Medicaid
  • $30,000 Aug 06, 2024 Issue: Medicare/Medicaid
  • $20,000 Jul 19, 2024 Issue: Medicare/Medicaid
  • $20,000 Jan 22, 2024 Issue: Medicare/Medicaid
  • $20,000 Oct 18, 2023 Issue: Medicare/Medicaid
  • $50,000 Jul 18, 2023 Issue: Medicare/Medicaid
  • $50,000 Jan 18, 2023 Issue: Medicare/Medicaid
  • $50,000 Oct 19, 2022 Issue: Medicare/Medicaid
  • $50,000 Jul 19, 2022 Issue: Medicare/Medicaid
  • $30,000 Apr 19, 2022 Issue: Medicare/Medicaid
  • $30,000 Jan 19, 2022 Issue: Medicare/Medicaid
  • $30,000 Oct 19, 2021 Issue: Medicare/Medicaid
  • $30,000 Jul 20, 2021 Issue: Medicare/Medicaid
  • $35,000 Apr 20, 2021 Issue: Medicare/Medicaid
  • $20,000 Jan 20, 2021 Issue: Medicare/Medicaid

Former government officials who have lobbied for MDXG

1 former government official at 1 lobbying firm has lobbied for MDXG, most recently Jul 20, 2026.

  • Jennifer Summa Other Former SF Investigative Counsel (detailed from CMS) Formerly Former SF Investigative Counsel (detailed from CMS) · BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Jul 20, 2026

MDXG Estimated quarterly lobbying spending

MDXG Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
MDXG Income Statement
MDXG Balance Sheet
MDXG Cash Flow
U.S. Patents

New MDXG patent grants

  • Patent Title: Placental tissue grafts May. 01, 2018
  • Patent Title: Tissue grafts composed of micronized placental tissue and methods of making and using the same Apr. 17, 2018
  • Patent Title: Methods of making implantable collagen fiber Jan. 23, 2018
  • Patent Title: Non-surgical, localized delivery of compositions for placental growth factors Nov. 28, 2017
  • Patent Title: Medical constructs including tubes and collagen fibers Oct. 31, 2017
  • Patent Title: Placental tissue grafts and improved methods of preparing and using the same Oct. 17, 2017
  • Patent Title: Synthetic collagen threads for cosmetic uses including skin wrinkle treatments and associated methods Jul. 04, 2017
  • Patent Title: Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same Jun. 27, 2017
  • Patent Title: Biostaples suitable for wrist, hand and other ligament replacements or repairs Jun. 20, 2017
  • Patent Title: Methods for treating cardiac conditions May. 30, 2017
  • Patent Title: Non-surgical, localized delivery of compositions for placental growth factors May. 23, 2017
  • Patent Title: Collagen fiber ribbons with integrated fixation sutures and methods of making the same May. 02, 2017
  • Patent Title: Methods of using compressible tubes for placing implants Apr. 04, 2017
  • Patent Title: Placental tissue grafts and methods of preparing and using the same Feb. 21, 2017
  • Patent Title: Dehydration device and methods for drying biological materials Jan. 31, 2017
  • Patent Title: Placental tissue grafts and methods of preparing and using the same Jan. 03, 2017
  • Patent Title: Placental tissue grafts Oct. 11, 2016
  • Patent Title: Cross-linked dehydrated placental tissue grafts and methods for making and using the same Oct. 11, 2016
  • Patent Title: Polymer chelator conjugates Sep. 20, 2016
  • Patent Title: Placental tissue grafts Sep. 06, 2016
  • Patent Title: Placental tissue grafts Aug. 16, 2016
  • Patent Title: Placental tissue grafts Mar. 01, 2016
  • Patent Title: Placental tissue grafts Mar. 01, 2016
  • Patent Title: Placental tissue grafts Feb. 23, 2016
  • Patent Title: Placental tissue grafts Feb. 23, 2016
  • Patent Title: Medical constructs of twisted lengths of collagen fibers and methods of making same Dec. 22, 2015
  • Patent Title: Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same Nov. 17, 2015
  • Patent Title: Compositions and methods for recruiting and localizing stem cells Nov. 10, 2015
  • Patent Title: Methods of making collagen fiber medical constructs and related medical constructs, including tubes Nov. 10, 2015
  • Patent Title: Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent Oct. 13, 2015
  • Patent Title: Biocomposite medical constructs including artificial tissues, vessels and patches Sep. 08, 2015
  • Patent Title: Placental tissue grafts and methods of preparing and using the same Jul. 21, 2015
  • Patent Title: Methods of making collagen fiber medical constructs and related medical constructs, including nerve guides and patches Jul. 14, 2015
  • Patent Title: Compressible tubes for placing implants and related medical kits and methods of using same Apr. 14, 2015
  • Patent Title: Implantable collagen devices and related methods and systems of making same Mar. 24, 2015
  • Patent Title: Cross-linked collagen comprising metallic anticancer agents Feb. 03, 2015
  • Patent Title: Cross-linked collagen comprising an antifungal agent Jan. 27, 2015
  • Patent Title: Placental tissue grafts Jan. 13, 2015
  • Patent Title: Dehydration device and methods for drying biological materials Dec. 09, 2014
  • Patent Title: Placental tissue grafts Apr. 29, 2014
  • Patent Title: Placental tissue grafts Apr. 29, 2014
  • Patent Title: Placental tissue grafts Apr. 22, 2014
  • Patent Title: Placental tissue grafts Apr. 22, 2014
  • Patent Title: Placental tissue grafts Feb. 04, 2014
  • Patent Title: Placental graft Jan. 07, 2014
  • Patent Title: Spinal disc implants with flexible keels and methods of fabricating implants Dec. 10, 2013
  • Patent Title: Methods for determining the orientation of a tissue graft Dec. 03, 2013
  • Patent Title: Methods for forming implants with selectively exposed mesh for fixation and related implants Jul. 02, 2013
  • Patent Title: Method for applying a label to a placental tissue graft Jun. 11, 2013
  • Patent Title: Placental tissue grafts Jun. 11, 2013
Government Contracts

Estimated quarterly amount awarded to MDXG from public contracts

MDXG News

Recent insights relating to MDXG

CNBC Recommendations

Recent picks made for MDXG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDXG

MDXG Analyst Ratings

MDXG Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MDXG Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MDXG stock a Buy, Sell, or Hold?

  • What is the price target for $MDXG stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MDXG Top Shareholders
Shareholder
Shares Held
MDXG Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MDXG stock?

  • Who owns the most shares of $MDXG stock?

  • What funds own $MDXG stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDXG Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDXG Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MDXG

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

  • Address Marietta, GA
  • Market Cap 696.1 million
  • Employees 808
  • Industrial Classification Surgical & Medical Instruments & Apparatus

MiMedx Group, Inc (MDXG) Historical Stock Prices

MiMedx Group, Inc (MDXG) closed at $4.77 on September 23, 2026. Over the past year its adjusted close ranged from $3.08 to $7.96. Daily prices go back to January 2, 2014, 3,193 trading days in all.

  • 1 month+11.71%
  • 3 months+24.54%
  • Year to date-29.54%
  • 1 year-32.91%
  • 3 years-37.07%
  • 5 years-23.68%
  • Max-43.55%
See every congressional and insider trade on the MDXG price chart

Quiver Premium charts MDXG's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 4.93 4.99 4.67 4.77 4.77 1,003,284
Sep 22, 2026 4.81 4.94 4.78 4.93 4.93 1,032,049
Sep 21, 2026 4.79 4.84 4.75 4.81 4.81 915,909
Sep 18, 2026 4.65 4.79 4.61 4.77 4.77 3,904,801
Sep 17, 2026 4.78 4.79 4.66 4.69 4.69 935,377
Sep 16, 2026 4.72 4.76 4.67 4.73 4.73 1,094,841
Sep 15, 2026 4.64 4.79 4.58 4.72 4.72 1,147,376
Sep 14, 2026 4.60 4.67 4.54 4.64 4.64 888,918
Sep 11, 2026 4.64 4.71 4.51 4.57 4.57 995,845
Sep 10, 2026 4.65 4.69 4.50 4.60 4.60 1,622,127
Sep 9, 2026 4.64 4.70 4.56 4.68 4.68 1,048,927
Sep 8, 2026 4.57 4.73 4.43 4.67 4.67 1,064,590
Sep 4, 2026 4.41 4.58 4.41 4.57 4.57 624,972
Sep 3, 2026 4.54 4.61 4.34 4.43 4.43 841,628
Sep 2, 2026 4.52 4.71 4.52 4.55 4.55 1,040,316
Sep 1, 2026 4.53 4.61 4.49 4.52 4.52 762,366
Aug 31, 2026 4.49 4.57 4.39 4.54 4.54 1,063,480
Aug 28, 2026 4.49 4.63 4.48 4.50 4.50 887,017
Aug 27, 2026 4.45 4.76 4.45 4.51 4.51 1,179,464
Aug 26, 2026 4.33 4.44 4.27 4.42 4.42 711,026
Aug 25, 2026 4.28 4.38 4.27 4.34 4.34 700,021
Aug 24, 2026 4.36 4.39 4.24 4.27 4.27 846,657
Aug 21, 2026 4.30 4.35 4.25 4.33 4.33 897,111
Aug 20, 2026 4.40 4.47 4.28 4.30 4.30 1,432,575
Aug 19, 2026 4.37 4.50 4.37 4.45 4.45 1,159,602
Aug 18, 2026 4.20 4.37 4.20 4.34 4.34 1,220,148
Aug 17, 2026 4.26 4.28 4.17 4.19 4.19 898,511
Aug 14, 2026 4.19 4.32 4.12 4.27 4.27 974,771
Aug 13, 2026 4.28 4.31 4.17 4.20 4.20 1,067,842
Aug 12, 2026 4.32 4.38 4.26 4.28 4.28 729,379
Aug 11, 2026 4.29 4.36 4.26 4.32 4.32 1,228,726
Aug 10, 2026 4.31 4.39 4.21 4.27 4.27 1,156,128
Aug 7, 2026 4.19 4.38 4.14 4.34 4.34 1,361,861
Aug 6, 2026 4.16 4.22 4.05 4.18 4.18 1,389,720
Aug 5, 2026 4.27 4.28 4.12 4.16 4.16 1,468,635
Aug 4, 2026 4.27 4.39 4.17 4.27 4.27 1,806,927
Aug 3, 2026 4.21 4.49 4.21 4.27 4.27 1,869,228
Jul 31, 2026 4.17 4.21 3.97 4.13 4.13 2,987,567
Jul 30, 2026 3.90 4.27 3.76 4.27 4.27 6,116,254
Jul 29, 2026 4.41 4.46 4.21 4.23 4.23 1,433,743
Jul 28, 2026 4.30 4.45 4.26 4.36 4.36 1,119,391
Jul 27, 2026 4.24 4.39 4.20 4.26 4.26 1,163,225
Jul 24, 2026 4.17 4.23 4.14 4.20 4.20 531,892
Jul 23, 2026 4.12 4.22 4.11 4.13 4.13 868,551
Jul 22, 2026 4.32 4.35 4.09 4.17 4.17 1,069,512
Jul 21, 2026 4.29 4.33 4.25 4.32 4.32 1,110,939
Jul 20, 2026 4.30 4.35 4.22 4.33 4.33 737,039
Jul 17, 2026 4.38 4.43 4.22 4.30 4.30 1,194,200
Jul 16, 2026 4.33 4.45 4.28 4.43 4.43 940,565
Jul 15, 2026 4.20 4.43 4.19 4.27 4.27 1,206,575
Jul 14, 2026 4.07 4.24 4.04 4.20 4.20 1,406,578
Jul 13, 2026 4.10 4.13 4.04 4.08 4.08 1,235,246
Jul 10, 2026 4.16 4.17 4.05 4.11 4.11 670,183
Jul 9, 2026 4.23 4.24 4.08 4.14 4.14 1,035,003
Jul 8, 2026 4.15 4.29 4.10 4.26 4.26 1,307,763
Jul 7, 2026 4.09 4.28 4.07 4.20 4.20 1,478,181
Jul 6, 2026 3.95 4.10 3.89 4.07 4.07 890,558
Jul 2, 2026 3.90 3.96 3.89 3.95 3.95 662,469
Jul 1, 2026 3.86 3.93 3.83 3.90 3.90 716,450
Jun 30, 2026 3.91 3.91 3.71 3.85 3.85 1,188,326
Jun 29, 2026 3.98 4.03 3.86 3.91 3.91 1,300,724
Jun 26, 2026 3.83 3.98 3.83 3.93 3.93 5,633,370
Jun 25, 2026 3.84 3.90 3.77 3.81 3.81 922,341
Jun 24, 2026 3.71 3.88 3.71 3.83 3.83 835,040
Jun 23, 2026 3.67 3.75 3.67 3.73 3.73 833,292
Jun 22, 2026 3.66 3.73 3.63 3.67 3.67 1,111,123
Jun 18, 2026 3.63 3.71 3.63 3.67 3.67 2,130,568
Jun 17, 2026 3.70 3.76 3.58 3.61 3.61 998,781
Jun 16, 2026 3.68 3.73 3.62 3.70 3.70 1,310,065
Jun 15, 2026 3.65 3.73 3.63 3.68 3.68 1,077,224
Jun 12, 2026 3.69 3.75 3.56 3.60 3.60 947,119
Jun 11, 2026 3.63 3.73 3.57 3.69 3.69 1,122,273
Jun 10, 2026 3.70 3.74 3.61 3.64 3.64 968,006
Jun 9, 2026 3.71 3.75 3.65 3.71 3.71 1,134,621
Jun 8, 2026 3.74 3.81 3.69 3.70 3.70 1,088,762
Jun 5, 2026 3.80 3.88 3.73 3.74 3.74 1,156,686
Jun 4, 2026 3.69 3.79 3.63 3.78 3.78 1,328,783
Jun 3, 2026 3.56 3.62 3.50 3.61 3.61 1,297,599
Jun 2, 2026 3.56 3.60 3.52 3.57 3.57 1,173,848
Jun 1, 2026 3.63 3.69 3.48 3.58 3.58 1,396,500
May 29, 2026 3.66 3.74 3.64 3.68 3.68 3,291,829
May 28, 2026 3.58 3.69 3.56 3.67 3.67 1,188,776
May 27, 2026 3.68 3.71 3.57 3.61 3.61 756,416
May 26, 2026 3.62 3.71 3.62 3.67 3.67 2,192,201
May 22, 2026 3.62 3.67 3.58 3.62 3.62 815,625
May 21, 2026 3.72 3.73 3.54 3.61 3.61 1,474,678
May 20, 2026 3.63 3.80 3.60 3.79 3.79 1,195,648
May 19, 2026 3.62 3.66 3.57 3.64 3.64 1,228,814
May 18, 2026 3.52 3.63 3.52 3.59 3.59 1,246,982
May 15, 2026 3.53 3.60 3.50 3.56 3.56 1,221,195
May 14, 2026 3.53 3.62 3.48 3.55 3.55 1,106,522
May 13, 2026 3.49 3.56 3.45 3.52 3.52 1,978,348
May 12, 2026 3.55 3.61 3.50 3.54 3.54 1,422,396
May 11, 2026 3.58 3.64 3.50 3.56 3.56 2,452,446
May 8, 2026 3.72 3.73 3.60 3.60 3.60 1,766,754
May 7, 2026 3.66 3.72 3.62 3.69 3.69 1,529,730
May 6, 2026 3.65 3.69 3.60 3.66 3.66 1,574,320
May 5, 2026 3.59 3.73 3.59 3.64 3.64 1,918,075
May 4, 2026 3.61 3.67 3.56 3.61 3.61 2,232,140
May 1, 2026 3.42 3.70 3.38 3.68 3.68 2,627,644
Apr 30, 2026 3.05 3.39 3.05 3.36 3.36 3,523,101
Apr 29, 2026 3.35 3.40 3.02 3.08 3.08 3,429,602
Apr 28, 2026 3.35 3.41 3.31 3.40 3.40 1,491,082
Apr 27, 2026 3.43 3.48 3.33 3.34 3.34 1,344,615
Apr 24, 2026 3.34 3.50 3.29 3.43 3.43 1,691,922
Apr 23, 2026 3.31 3.38 3.24 3.35 3.35 1,751,606
Apr 22, 2026 3.21 3.42 3.21 3.31 3.31 1,428,517
Apr 21, 2026 3.26 3.38 3.19 3.20 3.20 1,975,224
Apr 20, 2026 3.37 3.39 3.20 3.25 3.25 2,580,728
Apr 17, 2026 3.46 3.60 3.38 3.42 3.42 2,009,231
Apr 16, 2026 3.84 3.92 3.31 3.43 3.43 3,672,326
Apr 15, 2026 3.92 3.96 3.85 3.88 3.88 1,063,023
Apr 14, 2026 3.92 4.05 3.88 3.92 3.92 1,201,600
Apr 13, 2026 3.87 3.96 3.84 3.92 3.92 943,444
Apr 10, 2026 4.04 4.07 3.85 3.87 3.87 966,212
Apr 9, 2026 3.96 4.04 3.83 4.03 4.03 1,376,079
Apr 8, 2026 4.00 4.07 3.95 3.97 3.97 1,648,205
Apr 7, 2026 3.86 3.94 3.84 3.86 3.86 811,878
Apr 6, 2026 3.89 3.94 3.83 3.88 3.88 940,162
Apr 2, 2026 3.96 3.96 3.81 3.92 3.92 1,678,657
Apr 1, 2026 3.99 4.10 3.93 3.95 3.95 1,457,833
Mar 31, 2026 3.91 3.95 3.79 3.95 3.95 1,575,246
Mar 30, 2026 3.83 3.91 3.77 3.86 3.86 924,040
Mar 27, 2026 3.91 3.98 3.81 3.81 3.81 1,266,742
Mar 26, 2026 4.06 4.16 3.92 3.94 3.94 1,126,490
Mar 25, 2026 4.19 4.21 4.07 4.10 4.10 579,039
Mar 24, 2026 4.19 4.20 4.09 4.13 4.13 730,769
Mar 23, 2026 4.25 4.32 4.21 4.24 4.24 788,399
Mar 20, 2026 4.16 4.27 4.08 4.12 4.12 4,778,828
Mar 19, 2026 4.21 4.24 4.12 4.17 4.17 804,975
Mar 18, 2026 4.33 4.41 4.22 4.24 4.24 824,792
Mar 17, 2026 4.41 4.52 4.35 4.36 4.36 686,521
Mar 16, 2026 4.41 4.50 4.40 4.41 4.41 597,628
Mar 13, 2026 4.40 4.45 4.34 4.38 4.38 648,405
Mar 12, 2026 4.50 4.55 4.38 4.38 4.38 673,140
Mar 11, 2026 4.57 4.63 4.46 4.56 4.56 810,374
Mar 10, 2026 4.59 4.71 4.50 4.57 4.57 894,924
Mar 9, 2026 4.39 4.58 4.35 4.51 4.51 1,233,999
Mar 6, 2026 4.59 4.67 4.48 4.50 4.50 888,168
Mar 5, 2026 4.77 4.87 4.71 4.75 4.75 894,303
Mar 4, 2026 4.76 4.87 4.70 4.82 4.82 676,785
Mar 3, 2026 4.80 4.85 4.71 4.76 4.76 731,489
Mar 2, 2026 4.78 4.93 4.71 4.88 4.88 900,384
Feb 27, 2026 4.91 4.99 4.79 4.89 4.89 1,829,101
Feb 26, 2026 5.24 5.42 4.80 4.94 4.94 2,600,011
Feb 25, 2026 5.36 5.37 5.20 5.28 5.28 743,594
Feb 24, 2026 5.32 5.46 5.32 5.35 5.35 586,011
Feb 23, 2026 5.26 5.34 5.13 5.33 5.33 944,513
Feb 20, 2026 5.19 5.25 5.15 5.17 5.17 794,067
Feb 19, 2026 5.17 5.25 5.10 5.20 5.20 816,687
Feb 18, 2026 5.14 5.25 5.13 5.22 5.22 472,681
Feb 17, 2026 5.11 5.21 5.03 5.16 5.16 493,510
Feb 13, 2026 5.10 5.24 5.08 5.12 5.12 515,064
Feb 12, 2026 5.23 5.29 5.03 5.09 5.09 769,179
Feb 11, 2026 5.17 5.24 5.09 5.21 5.21 663,766
Feb 10, 2026 5.20 5.30 5.14 5.17 5.17 674,560
Feb 9, 2026 5.12 5.21 5.07 5.19 5.19 664,660
Feb 6, 2026 5.02 5.19 4.93 5.15 5.15 876,275
Feb 5, 2026 5.10 5.13 5.01 5.03 5.03 1,826,519
Feb 4, 2026 5.00 5.21 4.98 5.11 5.11 1,213,534
Feb 3, 2026 5.09 5.17 4.89 4.97 4.97 1,058,534
Feb 2, 2026 5.09 5.22 5.05 5.09 5.09 1,174,179
Jan 30, 2026 5.13 5.21 5.08 5.11 5.11 1,017,872
Jan 29, 2026 5.13 5.16 5.05 5.14 5.14 600,538
Jan 28, 2026 5.27 5.30 5.13 5.15 5.15 1,008,606
Jan 27, 2026 5.22 5.41 5.20 5.30 5.30 1,286,209
Jan 26, 2026 5.26 5.38 5.20 5.25 5.25 1,173,643
Jan 23, 2026 5.42 5.42 5.25 5.26 5.26 1,164,767
Jan 22, 2026 5.35 5.45 5.32 5.42 5.42 920,066
Jan 21, 2026 5.39 5.39 5.28 5.33 5.33 809,642
Jan 20, 2026 5.25 5.39 5.13 5.39 5.39 1,300,229
Jan 16, 2026 5.72 5.72 5.39 5.42 5.42 1,540,773
Jan 15, 2026 5.71 5.85 5.64 5.75 5.75 906,489
Jan 14, 2026 5.86 5.88 5.55 5.69 5.69 2,475,670
Jan 13, 2026 5.99 6.00 5.86 5.88 5.88 872,640
Jan 12, 2026 6.11 6.17 5.97 6.00 6.00 728,769
Jan 9, 2026 6.30 6.35 6.04 6.10 6.10 1,101,718
Jan 8, 2026 6.40 6.44 6.30 6.31 6.31 810,190
Jan 7, 2026 6.45 6.50 6.30 6.44 6.44 732,647
Jan 6, 2026 6.28 6.42 6.25 6.40 6.40 896,922
Jan 5, 2026 6.45 6.48 6.28 6.33 6.33 1,121,310
Jan 2, 2026 6.77 6.79 6.44 6.48 6.48 808,999
Dec 31, 2025 6.84 6.93 6.76 6.77 6.77 539,864
Dec 30, 2025 6.88 6.94 6.80 6.86 6.86 548,001
Dec 29, 2025 6.91 6.96 6.76 6.91 6.91 819,582
Dec 26, 2025 7.10 7.13 6.74 6.90 6.90 1,688,582
Dec 24, 2025 7.02 7.08 6.96 7.08 7.08 188,922
Dec 23, 2025 7.00 7.04 6.91 7.00 7.00 458,012
Dec 22, 2025 7.05 7.16 7.00 7.04 7.04 549,304
Dec 19, 2025 7.24 7.26 7.01 7.05 7.05 1,250,641
Dec 18, 2025 7.08 7.45 7.06 7.25 7.25 962,110
Dec 17, 2025 7.20 7.28 7.04 7.09 7.09 776,912
Dec 16, 2025 7.11 7.37 7.04 7.25 7.25 807,702
Dec 15, 2025 7.23 7.25 7.08 7.12 7.12 827,990
Dec 12, 2025 7.20 7.29 7.10 7.22 7.22 742,758
Dec 11, 2025 7.00 7.20 6.99 7.16 7.16 1,016,514
Dec 10, 2025 6.99 7.12 6.91 6.98 6.98 1,140,957
Dec 9, 2025 6.67 7.01 6.66 6.98 6.98 755,369
Dec 8, 2025 6.96 6.98 6.66 6.68 6.68 1,042,691
Dec 5, 2025 6.87 7.06 6.79 6.93 6.93 527,667
Dec 4, 2025 6.95 6.95 6.78 6.86 6.86 669,315
Dec 3, 2025 6.70 6.97 6.66 6.96 6.96 633,937
Dec 2, 2025 6.68 6.76 6.62 6.72 6.72 545,806
Dec 1, 2025 6.87 6.92 6.64 6.67 6.67 723,754
Nov 28, 2025 6.90 6.92 6.77 6.88 6.88 342,530
Nov 26, 2025 6.93 6.95 6.71 6.88 6.88 506,559
Nov 25, 2025 6.83 6.96 6.80 6.95 6.95 563,343
Nov 24, 2025 6.74 6.84 6.67 6.78 6.78 857,871
Nov 21, 2025 6.51 6.80 6.45 6.76 6.76 836,840
Nov 20, 2025 6.58 6.68 6.50 6.55 6.55 1,188,846
Nov 19, 2025 6.70 6.71 6.33 6.48 6.48 914,412
Nov 18, 2025 7.03 7.07 6.69 6.72 6.72 907,207
Nov 17, 2025 7.39 7.51 7.05 7.10 7.10 848,481
Nov 14, 2025 7.50 7.50 7.33 7.38 7.38 735,666
Nov 13, 2025 7.42 7.63 7.34 7.47 7.47 979,801
Nov 12, 2025 7.55 7.58 7.42 7.48 7.48 816,420
Nov 11, 2025 7.66 7.66 7.50 7.54 7.54 1,131,625
Nov 10, 2025 7.37 7.77 7.33 7.71 7.71 935,066
Nov 7, 2025 7.33 7.47 7.22 7.44 7.44 882,209
Nov 6, 2025 7.92 7.92 7.25 7.33 7.33 1,009,626
Nov 5, 2025 7.67 7.97 7.61 7.96 7.96 1,103,528
Nov 4, 2025 7.51 7.88 7.50 7.69 7.69 1,190,153
Nov 3, 2025 7.48 7.77 7.38 7.52 7.52 1,724,762
Oct 31, 2025 7.35 7.82 7.28 7.65 7.65 2,800,517
Oct 30, 2025 7.68 7.89 7.02 7.40 7.40 3,448,170
Oct 29, 2025 6.82 7.36 6.74 7.19 7.19 3,050,418
Oct 28, 2025 6.71 6.89 6.68 6.88 6.88 521,644
Oct 27, 2025 6.76 6.80 6.68 6.73 6.73 581,140
Oct 24, 2025 6.65 6.79 6.60 6.76 6.76 529,655
Oct 23, 2025 6.72 6.72 6.58 6.64 6.64 429,413
Oct 22, 2025 6.76 6.80 6.64 6.72 6.72 591,485
Oct 21, 2025 6.75 6.86 6.71 6.74 6.74 294,856
Oct 20, 2025 6.69 6.75 6.61 6.75 6.75 392,862
Oct 17, 2025 6.62 6.70 6.54 6.69 6.69 495,556
Oct 16, 2025 6.73 6.86 6.58 6.63 6.63 464,020
Oct 15, 2025 6.61 6.76 6.60 6.71 6.71 580,697
Oct 14, 2025 6.46 6.64 6.41 6.58 6.58 466,844
Oct 13, 2025 6.58 6.66 6.45 6.51 6.51 502,308
Oct 10, 2025 6.91 6.96 6.50 6.55 6.55 560,067
Oct 9, 2025 7.24 7.24 6.88 6.92 6.92 427,780
Oct 8, 2025 7.28 7.30 7.09 7.10 7.10 524,553
Oct 7, 2025 7.30 7.35 7.20 7.26 7.26 1,461,281
Oct 6, 2025 7.21 7.33 6.99 7.31 7.31 1,321,822
Oct 3, 2025 6.73 7.22 6.71 7.21 7.21 1,322,849
Oct 2, 2025 6.82 6.82 6.62 6.71 6.71 652,125
Oct 1, 2025 6.94 7.00 6.81 6.83 6.83 403,105
Sep 30, 2025 6.91 7.01 6.85 6.98 6.98 489,396
Sep 29, 2025 6.98 7.04 6.83 6.93 6.93 483,946
Sep 26, 2025 7.01 7.01 6.81 6.94 6.94 550,266
Sep 25, 2025 6.98 7.07 6.89 6.98 6.98 441,823
Sep 24, 2025 7.10 7.19 7.03 7.09 7.09 334,752
Sep 23, 2025 7.25 7.25 7.05 7.11 7.11 389,497

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
MiMedx Group, Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at MDXG, per a recent SEC DEF 14A filing. We estimate that the median employee at MIMEDX GROUP, INC. is paid $100,298.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation